Pneumatic Nebulizers Market

Pneumatic Nebulizers Market (Product Type: Breath-actuated Nebulizer and Vented Nebulizer; and Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Pneumatic Nebulizers Market Outlook 2031

  • The global industry was valued at US$ 648.0 Mn in 2021
  • It is projected to advance at a CAGR of 7.3% from 2022 to 2031 and reach more than US$ 1.3 Bn by the end of 2031

Analysts’ Viewpoint

Demand for pneumatic nebulizers is increasing across the globe due to the rise in prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Environmental pollution, smoking, and changing lifestyles are contributing to the growth in prevalence of respiratory disorders. Technological advancements in healthcare devices and increase in number of geriatric patients are driving the global pneumatic nebulizers market.

Development of technologically advanced pneumatic nebulizers presents significant opportunities for market players. Companies are focusing on accelerating product development in order to gain competitive edge over other players. However, drug loss during delivery is likely to hamper pneumatic nebulizers market revenue during the forecast period.

Pneumatic Nebulizers Market

Pneumatic Nebulizers Market Introduction

Pneumatic nebulizers are devices that convert liquid medication into a fine mist or aerosol that can be inhaled through a mouthpiece or mask. These devices use compressed air or oxygen to create mist, making them more portable and easy to use than other types of nebulizer.

Pneumatic nebulizers are used to treat respiratory conditions such as asthma, COPD, and cystic fibrosis. Portable nebulizer machine is also used in industrial and laboratory settings for nebulization of liquids and solutions.

These devices use compressed air or oxygen to create a high-velocity stream of air that breaks up the liquid medication into small droplets, which can be inhaled. Jet nebulizers are used in healthcare settings; however, they can also be used at home under the guidance of a healthcare provider.

Vented and breath-actuated are the two primary types of pneumatic nebulizer. Pneumatic nebulizer is the most widely used device due to its suitability for all types of medications. Furthermore, the device is easy to handle and less expensive than other types of nebulizers (ultrasonic and mesh).

Request a sample to get extensive insights into the Pneumatic Nebulizers Market

Surge in Number of COPD, Asthma, and Cystic Fibrosis Patients

Asthma, cystic fibrosis, and COPD are chronic lung conditions that affect millions of people globally. Prevalence of these conditions varies by country and region; however, they are considered major public health concerns.

Asthma is a chronic lung disease that causes inflammation and narrowing of the airways, making it difficult to breathe. According to the World Health Organization (WHO), asthma affected around 262 million people across the world in 2019. It is the most common chronic pediatric disease that affects 14% of all children across the globe every year.

Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, causing buildup of thick, sticky mucus. It affects around 35,000 people in the U.S. every year.

COPD is a group of lung conditions that makes breathing difficult. The most common causes of COPD are smoking and long-term exposure to air pollution. According to the World Health Organization (WHO), COPD accounted for 3.23 million deaths worldwide in 2019. Nearly 90% COPD deaths occur in low & middle income countries.

Advancements in Technology to Bolster Pneumatic Nebulizers Market Share

Advancements in technology have made nebulizers more portable and convenient for patients to use at home. Modern nebulizers are smaller, lighter, and battery-operated, which makes them easy to carry around and use in various settings. Hence, patients are likely to use these devices as directed by the healthcare provider.

Some nebulizers carry features such as wireless connectivity, which allows patients to track their treatment progress and receive reminders to take medication. This is likely to improve compliance, and thereby lead to better health outcomes.

Request a custom report on Pneumatic Nebulizers Market

Higher Drug Delivery Capacity and Less Dosage Waste

In terms of product type, the global pneumatic nebulizers market has been bifurcated into breath-actuated nebulizer and vented nebulizer. The breath-actuated segment dominated the global market with significant share in 2021.

Breath-actuated pneumatic nebulizers have a higher drug delivery capacity and less dosage waste. Hence, they provide advanced inhalation therapy. These factors are ascribed to the segment's dominance of the market.

Higher Prevalence of COPD

Based on application, the COPD segment accounted for major share of the global market in 2021. COPD is more prevalent than asthma, cystic fibrosis, and others. It is a progressive disease, which makes breathing more difficult as it worsens.

Severe COPD could lead to respiratory failure, which can be fatal. Hence, demand for pneumatic nebulizers is increasing among COPD patients.

Decrease in Hospital Visits and Spread of Viruses

In terms of end-user, the global pneumatic nebulizers market has been divided into hospitals & clinics, home healthcare, and others. The home healthcare segment accounted for the largest share of the global market in 2021. Pneumatic nebulizers enable individuals to administer medication to themselves, which could help reduce the number of hospital visits and spread of viruses.

Regional Analysis of Global Pneumatic Nebulizers Market Size

North America accounted for major share of the global market in 2021. The market in the region is likely to expand at a high CAGR from 2022 to 2031. This can be ascribed to the high rate of adoption of pneumatic nebulizers in the region.

Rise in prevalence of various respiratory disorders such as COPD, asthma, and cystic fibrosis is propelling market expansion in the region. Technological advancements in healthcare and increase in adoption of home healthcare are the other factors fueling market statistics in the region.

As per pneumatic nebulizers market report, Asia Pacific held the second largest share in 2021. The market in the region is likely to grow at a rapid pace from 2022 to 2031. This can be ascribed to the increase in number of COPD and asthma patients in Asia Pacific.

According to Global Burden of Disease Study 2019, about 72 million people in India suffered from obstructive airway diseases (OAD) such as asthma and COPD during the year. Additionally, technological advancements and new product development are expected to augment market progress in the region during the forecast period.

Analysis of Key Players

The global pneumatic nebulizers market is fragmented, with the presence of large number of local as well as international players. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by the leading players.

Prominent players in the industry are Beurer GmbH, Besco Medical Co., Ltd., Bremed Ltd., Drive DeVilbiss Healthcare, GE HealthCare, Koninklijke Philips N.V., Morepen Laboratories Ltd., Nidek Medical Products, Inc., OMRON Healthcare, Inc., PARI Pharma GmbH, Rossmax International Ltd., SunMed, and Vectura Group plc.

Each of these players has been profiled in the pneumatic nebulizers market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

Key Developments

  • In March 2021, PARI Pharma GmbH announced the LAMIRA Nebulizer System authorization for the delivery of Insmed's drug product ARIKAYCE in Japan

Global Pneumatic Nebulizers Market Snapshot

Attribute

Detail

Size in 2021

US$ 648.0 Mn

Forecast (Value) in 2031

More than US$ 1.3 Bn

Growth Rate

(CAGR)

7.3%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn/Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product Type
    • Breath-actuated Nebulizer
    • Vented Nebulizer
  • Application
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Asthma
    • Cystic Fibrosis
    • Others
  • End-user
    • Hospitals & Clinics
    • Home Healthcare
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Beurer GmbH
  • Besco Medical Co., Ltd.
  • Bremed Ltd.
  • Drive DeVilbiss Healthcare
  • GE HealthCare
  • Koninklijke Philips N.V.
  • Morepen Laboratories Ltd.
  • Nidek Medical Products, Inc.
  • OMRON Healthcare, Inc.
  • PARI Pharma
  • Rossmax International Ltd.
  • SunMed
  • Vectura Group plc

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global pneumatic nebulizers market in 2021?

The global industry was valued at US$ 648.0 Mn in 2021.

How big will it be in 2031?

It is projected to reach more than US$ 1.3 Bn by 2031.

What will be the CAGR during the forecast period?

The CAGR is anticipated to be 7.3% from 2022 to 2031.

What are the prominent trends that affect growth?

Surge in prevalence of COPD, asthma, and cystic fibrosis; and advancement in technology.

Which region is likely to account for major share during the forecast period?

North America is expected to account for the largest share during the forecast period.

Who are the prominent players in the sector?

Beurer GmbH, Besco Medical Co., Ltd., Bremed Ltd., Drive DeVilbiss Healthcare, GE HealthCare, Koninklijke Philips N.V., Morepen Laboratories Ltd., Nidek Medical Products, Inc., OMRON Healthcare, Inc., PARI Pharma GmbH, Rossmax International Ltd., SunMed, and Vectura Group plc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Pneumatic Nebulizers Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Pneumatic Nebulizers Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Key Industry Events

        5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

    6. Global Pneumatic Nebulizers Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Breath-actuated Nebulizer

            6.3.2. Vented Nebulizer

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Pneumatic Nebulizers Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            7.3.2. Asthma

            7.3.3. Cystic Fibrosis

            7.3.4. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Pneumatic Nebulizers Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals & Clinics

            8.3.2. Home Healthcare

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Pneumatic Nebulizers Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Pneumatic Nebulizers Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017–2031

            10.2.1. Breath-actuated Nebulizer

            10.2.2. Vented Nebulizer

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            10.3.2. Asthma

            10.3.3. Cystic Fibrosis

            10.3.4. Others

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals & Clinics

            10.4.2. Home Healthcare

            10.4.3. Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Pneumatic Nebulizers Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Breath-actuated Nebulizer

            11.2.2. Vented Nebulizer

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            11.3.2. Asthma

            11.3.3. Cystic Fibrosis

            11.3.4. Others

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals & Clinics

            11.4.2. Home Healthcare

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Breath-actuated Nebulizer

            12.2.2. Vented Nebulizer

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            12.3.2. Asthma

            12.3.3. Cystic Fibrosis

            12.3.4. Others

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals & Clinics

            12.4.2. Home Healthcare

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Pneumatic Nebulizers Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Breath-actuated Nebulizer

            13.2.2. Vented Nebulizer

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            13.3.2. Asthma

            13.3.3. Cystic Fibrosis

            13.3.4. Others

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals & Clinics

            13.4.2. Home Healthcare

            13.4.3. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. Breath-actuated Nebulizer

            14.2.2. Vented Nebulizer

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            14.3.2. Asthma

            14.3.3. Cystic Fibrosis

            14.3.4. Others

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Hospitals & Clinics

            14.4.2. Home Healthcare

            14.4.3. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product Type

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2021

        15.3. Company Profiles

            15.3.1. Beurer GmbH

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Strategic Overview

            15.3.2. Besco Medical Co., Ltd.

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Strategic Overview

            15.3.3. Bremed Ltd.

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Strategic Overview

            15.3.4. Drive DeVilbiss Healthcare

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Strategic Overview

            15.3.5. GE HealthCare

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Strategic Overview

            15.3.6. Koninklijke Philips N.V.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Strategic Overview

            15.3.7. Morepen Laboratories Ltd.

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Strategic Overview

            15.3.8. Nidek Medical Products, Inc.

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Strategic Overview

            15.3.9. OMRON Healthcare, Inc.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Strategic Overview

            15.3.10. PARI Pharma GmbH

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Product Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Strategic Overview

            15.3.11. Rossmax International Ltd.

                15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.11.2. Product Portfolio

                15.3.11.3. SWOT Analysis

                15.3.11.4. Strategic Overview

            15.3.12. SunMed

                15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.12.2. Product Portfolio

                15.3.12.3. SWOT Analysis

                15.3.12.4. Strategic Overview

            15.3.13. Vectura Group plc

                15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.13.2. Product Portfolio

                15.3.13.3. SWOT Analysis

                15.3.13.4. Strategic Overview

    List of Tables

    Table 01: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 06: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 07: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 08: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 09: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 10: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 11: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 12: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 13: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 14: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 18: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 19: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 20: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 21: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 22: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 23: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 24: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031

    Figure 03: Global Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 04: Global Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031

    Figure 05: Global Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 06: Global Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 07: Global Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 08: Global Pneumatic Nebulizers Market Analysis and Forecast, by Region, 2021 and 2031

    Figure 09: Global Pneumatic Nebulizers Market Attractiveness Analysis, by Region, 2022–2031

    Figure 10: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031

    Figure 11: North America Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031

    Figure 12: North America Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 13: North America Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031

    Figure 14: North America Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 15: North America Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 16: North America Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 17: North America Pneumatic Nebulizers Market Analysis and Forecast, by Country, 2021 and 2031

    Figure 18: North America Pneumatic Nebulizers Market Attractiveness Analysis, by Country, 2022–2031

    Figure 19: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031

    Figure 20: Europe Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031

    Figure 21: Europe Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 22: Europe Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031

    Figure 23: Europe Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 24: Europe Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 25: Europe Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 26: Europe Pneumatic Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

    Figure 27: Europe Pneumatic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 28: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031

    Figure 29: Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031

    Figure 30: Asia Pacific Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 31: Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031

    Figure 32: Asia Pacific Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 33: Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 34: Asia Pacific Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 35: Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

    Figure 36: Asia Pacific Pneumatic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 37: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031

    Figure 38: Latin America Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031

    Figure 39: Latin America Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 40: Latin America Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031

    Figure 41: Latin America Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 42: Latin America Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 43: Latin America Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 44: Latin America Pneumatic Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

    Figure 45: Latin America Pneumatic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 46: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031

    Figure 47: Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031

    Figure 48: Middle East & Africa Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031

    Figure 49: Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031

    Figure 50: Middle East & Africa Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 51: Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031

    Figure 52: Middle East & Africa Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 53: Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

    Figure 54: Middle East & Africa Pneumatic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 55: Global Pneumatic Nebulizers Market Share Analysis/Ranking, by Company, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved